Leerink Partners Maintains Outperform on Pharvaris, Raises Price Target to $65
Benzinga Newsdesk 1 month ago
NewsPrice TargetAnalyst Ratings
Leerink Partners analyst Joseph Schwartz maintains Pharvaris (NASDAQ:PHVS) with a Outperform and raises the price target from $50 to $65.
Leerink Partners analyst Joseph Schwartz maintains Pharvaris (NASDAQ:PHVS) with a Outperform and raises the price target from $50 to $65.